Health Watch Home
Health Care Value
Transparency Costs
Transparency Quallity
Health Care Competition
Freedom of Information
  Report an Incident
  Join Health Watch
 Search Health Watch
Subscribe to Health Watch USA's Newsletter

To contact Health Watch USA please  use the following E-Mail Address

Content in this website may be linked to, as long as the linking webpage and passage has a known and clearly stated author.


Is the Rise in RSV Infections Associated With Immune Debt or SARS-CoV-2 Immune Dysfunction?    

View OpEd:      

1. News Release. CDC. Nov. 4, 2022. Accessed on Feb. 10, 2023 from
2. National Center for Educational Statistics (NCES). School Learning in Children. Updated Jan. 6, 2023. Accessed on Feb. 10, 2023 from
3. Clarke KEN, Jones JM, Deng Y, et al. Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022. MMWR Morb Mortal Wkly Rep. 2022 Apr 29;71(17):606-608. doi: 10.15585/mmwr.mm7117e3.
4. Jia R, Lu L, Su L, et al. Resurgence of Respiratory Syncytial Virus Infection During COVID-19 Pandemic Among Children in Shanghai, China. Front Microbiol. 2022 Jul 1;13:938372. doi: 10.3389/fmicb.2022.938372. eCollection 2022. Accessed on Feb. 10, 2023 from
5. Wang L, Davis PB, Berger NA, et al. Disruption in seasonality, patient characteristics and disparities of respiratory syncytial virus infection among young children in the US during and before the COVID-19 pandemic: 2010-2022. medRxiv. Nov. 29, 2022. Accessed on Feb. 10, 2023 from
6. Mizrahi B, Sudry T, Flaks-Manov N, et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023 Jan 11;380:e072529. doi: 10.1136/bmj-2022-072529.: Accessed on Feb. 10, 2023 from
7. Phetsouphanh, C., Darley, D.R., Wilson, D.B. et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022 Feb;23(2):210-216. doi: 10.1038/s41590-021-01113-x. Epub 2022 Jan 13. Accessed on Feb. 10, 2023 from
8. Shen, XR., Geng, R., Li, Q. et al. ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal Transduct Target Ther. 2022 Mar 11;7(1):83. doi: 10.1038/s41392-022-00919-x. Accessed on Feb. 10, 2023 from
9. Khoo WH, Jackson K, Phetsouphanh C, et al. Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19. Clin Immunol. 2023 Jan;246:109209. doi: 10.1016/j.clim.2022.109209. Epub 2022 Dec 17. Accessed on Feb. 10, 2023 from
10. Bowe, B., Xie, Y. & Al-Aly, Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022 Nov;28(11):2398-2405. doi: 10.1038/s41591-022-02051-3. Epub 2022 Nov 10. Accessed on Feb. 10, 2023 from
11. RSV National Trends. The National Respiratory and Enteric Virus Surveillance System (NREVSS) Centers for Disease Control and Prevention.
12. Cohen R, Ashman M, Taha MK, et al. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infectious Diseases Now. Aug. 2021.
13. Leonardi AJ, Proenca RB. Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19. Front. Immunol. December 21, 2020
14. COVID-19 Response Reporting. Jan. 19, 2023.
15. Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. April 2021.
16. Mina MJ, Kula T, Leng Y. et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science. Nov. 1, 2019.
17. Statens Serum Institut - RS-virus. Jan. 1, 2023.
18. Current weekly report on RSV. The Public Health Agency of Sweden.
19. Sweden’s Pandemic Experiment. Edited BySigurd Bergmann, Martin Lindström Dec. 18, 2022.

RSV Epidemiological Curves in Sweden, United States, China, Denmark

All information contained on this website is the express opinion of Health Watch USA. lth Watch USA, inc. is a non-profit 501C3 organization based in Kentucky